Vascular Perfusion Solutions and Unravel Biosciences Announce Partnership To Modulate Endothelial Activation During Heart Preservation To Improve Heart Transplant Outcomes

The partnership between Vascular Perfusion Solutions and Unravel Biosciences, Inc. utilizes Unravel’s target and drug discovery platform, BioNAV™, which leverages a gene expression network AI model of human health to advance drugs for complex diseases in a target-agnostic manner, to identify small molecule modulators of endothelial activation.